Great Lakes Retirement’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-54
Closed -$17.6K – 673
2024
Q2
$17.6K Sell
54
-543
-91% -$192K ﹤0.01% 421
2024
Q1
$236K Sell
597
-57
-9% -$21.1K 0.04% 210
2023
Q4
$230K Sell
654
-80
-11% -$28.3K 0.04% 207
2023
Q3
$275K Sell
734
-219
-23% -$84.7K 0.05% 201
2023
Q2
$365K Buy
953
+10
+1% +$3.57K 0.06% 186
2023
Q1
$327K Buy
+943
New +$276K 0.06% 194

Other funds holding WST

Great Lakes Retirement's WST Position: Q3 2024 in Review

Great Lakes Retirement sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 54 shares — an estimated $17.6K sold.

Great Lakes Retirement first reported a position in WST in Q1 2023 and held it in 6 quarters. The position peaked at $365K in Q2 2023. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Great Lakes Retirement reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Great Lakes Retirement sold 54 West Pharmaceutical shares in Q3 2024, an estimated $17.6K.
  • Great Lakes Retirement first reported a position in West Pharmaceutical in Q1 2023 and held it in 6 quarters.
  • Great Lakes Retirement's West Pharmaceutical position peaked at $365K in Q2 2023.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Great Lakes Retirement's 13F filing for Q3 2024, filed 22 Oct 2024.